AerBetic Announces Wearable Alert Device for People with Diabetes
The non-invasive device, to be demonstrated at CES 2019, uses gas sensors to inform and alert diabetes patients and their caregivers.
AerBetic, Inc. announced today that it is developing a non-invasive, wearable diabetes alert system that will improve quality of life and simplify caregiving for the 460 million people worldwide living with diabetes.
The device contains nano-sensors that detect gases given off through breath or skin, which are symptomatic of high or low blood sugar. The tiny sensors, designed and manufactured by AerNosTM, will be integrated into wearable devices that pair with smartphone apps, adding the ability to push alerts to patients and caregivers.
AerBetic will demo the technology and prototype in AerNos booth 42349 at the Sands Expo during CES 2019, January 8-11 in Las Vegas, Nevada.
CEO Arnar Thors said the idea for AerBetic came from his family pet. “Many diabetics use specially trained dogs with a keen sense of smell to detect increases of Volatile Organic Compounds in the exhaled breath of their subjects with diabetes,” Thors said. “We have developed a wearable solution that will detect these same gas patterns. The ability to determine a patient’s status without the need for invasive and costly sensors will enable a higher quality of life for diabetes patients and their caregivers worldwide.”
Since formation in July of 2018, AerBetic has been awarded a research grant from Southern Research and has won the Alabama Launchpad startup competition.
According to Thors, the sensors will use patient data and feedback to improve and fine tune over time, employing machine learning and artificial intelligence to increase fidelity to the individual user level, as well as network-wide. “The more a patient uses it, the more attuned to that patient it becomes,” Thors explained.
"Type 1 Diabetics – and caregivers of Type 1 Diabetics – have been asking for a non-invasive monitoring solution for some time,” said Kristen Noles, DNP, RN, CNL and Nurse Leader at the University of Alabama at Birmingham. “AerBetic’s vision of incorporating a gas sensor that improves and gets smarter over time will be a game changer. The ability to reliably monitor patients remotely will drastically improve the quality of life for people with diabetes and their caregivers.”
AerBetic is in the final stages of development, with testing slated to begin early Q1, 2019, and the first production units to ship in Q4 2019 .